Clients
I-HUB

Analytik Jena
Develops liquid handling products to provide laboratory automation solutions and robotic systems for the life science industry.

Arborea
A cleantech start-up (Climate-KIC), provides cutting edge and sustainable green building technologies.
Central Working and Curesponse

Central Working
Offers office spaces, hot-desking areas and meeting room. Central Working’s network of eleven designed clubs across the UK provide businesses with the environment, community and support.

Curesponse
Curesponse’s technology represents the next step in personalized cancer medicine, moving prediction capabilities beyond genomics and into the world of functional response on living patient cells.
Datar and DnaNudge

Datar Cancer Genetics
Datar Cancer Genetics provides customized oncology solutions for cancer patients based on molecular analysis of tissue/blood based genetic profiles.

DnaNudge
The concept of DnaNudge is to 'nudge' consumers while shopping towards healthy food choices based upon their DNA. Through the Nudge Box, the Nudge Cartridge and wearable DNAband.
Facesoft and H Robotics

Facesoft
Facesoft use Machine Learning to unlock the potential of Face Analysis. Facesoft are industry leaders in Face Analysis Technologies: Face Detection, Face Landmarks, Face Matching and Face Recognition.

H Robotics
H Robotics develops autonomous drones for industry. It’s core product HiSight is a deep data aerial intelligence system; it can empower the mining industry in its push for digital transformation.
ICON and ICWCI

ICON
ICON is the leading Patient-Centered Research company serving academia, life science researchers, and the pharmaceutical industry. Our commitment to patients is reflected through our wide range of services, including Real World Evidence, HEOR, Linguistic Validation, Global Market Access, and Research.

Imperial White City Incubator
A space dedicated to small, early-stage technology businesses, provides office and laboratory facilities, training, support and access to professional networks.
Invitro Genetics and LIfT BioSciences

Invitro Genetics
IVF Laboratory consumables, tools and equipment provider, trading name is CooperGenomics. Provide the PGTai technology platform for Preimplantation Genetic Screening.

LIfT BioSciences
Develops Immuno-Oncology Cell Therapy called N-LIfT (Neutrophil only Leukocyte Infusion Therapy) that has the potential to destroy all solid tumours irrespective of mutation or strain.
Lightsource Labs and Micrographia Bio

Lightsource Labs
Lightsource Labs manage large-scale solar projects and smart energy for businesses and communities.

Micrographia Bio
Micrographia Bio is a next-generation drug-discovery startup, operating at the intersection between AI, engineering, and biology. It's technology can roll 1000s of experiments into a single assay to create the atlas for modern medicine.
MINA & NPL

MiNA Therapeutics
Harnessing the innate mechanism of gene activation, MiNA Therapeutics’ platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases.

National Physical Laboratory
NPL is the UK's National Measurement Institute, developing and maintaining the national primary measurement standards.
ORCA & Polymateria

ORCA Computing
ORCA Computing is building the first scalable and flexible quantum computer powered by photonics. ORCA’s processor and architecture leverage photonics connectivity to unlock performance and scale for quantum computing 2.0.

Polymateria
Polymateria is a British business developing a new standard in biodegradable and compostable plastics. Polymateria scientists have created a breakthrough, proprietary formulation for plastics - called Biotransformation - that makes it possible.
Precision Robotics and Pulmocide

Precision Robotics
Develops medical robots to conduct colorectal oncology surgeries. Spin-out company from Imperial Innovations and the Hamlyn Centre.

Pulmocide
Develops the leading range of first-in-class inhaled anti-infective for targeted treatment of life threatening lung infections.
Quell and SynbiCITE

Quell
An early stage cancer therapy. Develop engineering T-regulatory cell (Treg) therapies for a solid organ transplant and autoimmune conditions.

SynbiCITE
SynbiCITE is the Innovation and Knowledge Centre (IKC) for Synthetic Biology. With the objective is to accelerate and promote the commercial exploitation of synthetic biology research and engineering biology applications.